1 / 61

Allergic Rhinitis

Allergic Rhinitis. Dr. Vishal Sharma. Introduction.  C ommonest chronic disease of mankind (20%)  Induced after allergen exposure by IgE-mediated Type 1 hypersensitivity reaction of nasal mucosa  30% pt of allergic rhinitis have bronchial asthma

dcorrea
Télécharger la présentation

Allergic Rhinitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Allergic Rhinitis Dr. Vishal Sharma

  2. Introduction  Commonest chronic disease of mankind (20%) Induced after allergen exposure by IgE-mediated Type 1 hypersensitivity reaction of nasal mucosa  30% pt of allergic rhinitis have bronchial asthma  60-80% pt of asthma also have allergic rhinitis  Prevention of allergen exposure is best treatment

  3. Aetiology 1. ATOPY:genetically inherited ed IgE response 2. ALLERGENS: * Seasonal (Hay fever):Pollen, Fungus * Perennial:Dust mite, Domestic pets, Cockroaches * Occupational (?):Flour, Animal, Wood, Latex, Paint 3. FOOD INDUCED:Nuts, fish, prawns, legumes, milk, cheese, egg, meat, citrus fruits, wines

  4. 4. DRUG INDUCED:Aspirin, other NSAIDs, anti-hypertensives, oral contraceptive pills 5. POLLUTION (NASAL IRRITANTS):Traffic fumes, tobacco smoke, mosquito repellents, perfumes, scented sticks, domestic sprays, bleaches 6. LACK OF INFECTION:Younger child in large family  frequent viral infections & less prone to allergy. Older child in large family or only child in a small family  infection is rare so develops allergy.

  5. Grass pollen & dust mite

  6. Pathogenesis Sensitization & Priming to specific antigen: Inhaled allergen produces specific IgE antibody which gets attached to mast cells Subsequent exposure to same antigen: Allergen combines with specific IgE antibody  degranulation of mast cells (even with small amount of antigen)  chemical mediators released

  7. Acute or Early Phase Occurs 5–30 min after exposure to antigen due to release of chemical mediators sneezing, watery rhinorrhoea, nasal blockage & bronchospasm.  Mucosal edema&Vasodilation nose block  Nerve irritation sneezing & itching  ed secretion from nasal gland rhinorrhoea  Smooth muscle contraction bronchospasm

  8. Late or Delayed Phase Occurs 2-8 hours after exposure due to infiltration by inflammatory cells at site of antigen deposition  edema, congestion & thick nasal secretion. Sneezing & itching decreases. Inflammatory cells are eosinophils, neutrophils, basophils, monocytes & CD4+ T lymphocytes.

  9. Pathogenesis

  10. Pathogenesis

  11. Cardinal Symptoms 1.Watery rhinorrhoea 2.Nasal obstruction: bilateral 3.Paroxysmal sneezing: 10-20 at a time 4.Itching in nose, eyes, palate, pharynx Presence of 2 or more symptoms for > 1 hour on most days indicates allergic rhinitis.

  12. Nasal Signs • Repeated lifting of nasal tip (allergic salute) to relieve itching & open nasal airway transverse nasal crease (Darrier’s crease, Hilton’s line). • Hypertrophied turbinates are covered with pale or blue, boggy mucosa. Pitting edema seen on probing (mulberry turbinates). • Nasal secretions are watery  mucoid. • Nasal polyps with hyposmia / anosmia.

  13. Allergic salute

  14. Nasal crease

  15. Pale turbinate, watery rhinorrhoea

  16. Blue, boggy turbinate

  17. Inferior turbinate appearances

  18. Other Clinical Signs Face: Frequent twitching of face (bunny nose)  Dennie-Morgan creases (in lower eyelid skin)  Allergic shiners (dark discoloration below lower eyelids) caused by venous stasis Eyes: Conjunctiva is congested with cobble stone appearance; increased lacrimation Ears: Ear block & ed hearing (due to O.M.E.) Throat: Chronic pharyngitis, laryngitis

  19. Dennie-Morgan Creases

  20. Allergic Shiners

  21. Allergic conjunctivitis

  22. ARIA Classification 1. Mild intermittent 2. Moderate-severe intermittent 3. Mild persistent 4. Moderate-severe persistent ARIA = Allergic Rhinitis & its Impact on Asthma

  23. Intermittent symptoms Persistent symptoms Present for < 4 days / wk Present for > 4 days / wk Or for < 4 weeks and for > 4 weeks Mild (presence of all) Moderate-severe (any 1)  Normal sleep  Abnormal sleep  Normal daily activities  Impaired daily activities  Normal work and school  Impaired work & school  Normal sport & leisure  Impaired sport & leisure  No troublesome symptom  Troublesome symptoms +

  24. Investigations • Absolute Eosinophil count • Nasal smear examination for eosinophils • Skin prick test • Radio-allergo-sorbent test (R.A.S.T.) • Diagnostic Nasal Endoscopy • C.T. scan P.N.S.:for sinusitis & nasal polyps

  25. Skin prick test

  26. Skin prick test

  27. Skin prick test

  28. Radio-allergo-sorbent test

  29. Pt serum is incubated with allergen disc. Only specific IgE binds with allergen. Rest is washed away with a buffer. • Disc is incubated with radio-labeled anti - IgE antibody. Anti-IgE antibody binds with allergen-IgE complex. • Amount of radio-labelled anti-IgE antibody on disc  amount of IgE & is quantified by counting radioactivity from the disc.

  30. Complications • Recurrent sinusitis • Nasal polyp • Serous otitis media • Prolonged mouth breathing • Bronchial asthma • Atopic dermatitis • Conjunctivitis

  31. Differential diagnosis • Vasomotor rhinitis • Rhinitis medicamentosa • Hormonal rhinitis (pregnancy, hypothyroidism, oral contraceptive use) • Cerebrospinal fluid leak • Ethmoid polyps

  32. Treatment • Avoidance of allergens • Pharmacotherapy • Specific Immunotherapy • Surgery: F.E.S.S., Turbinoplasty

  33. Pharmacotherapy H1-Antihistamines: Topical (Azelastine), Systemic Nasal Decongestants:Topical drops, Systemic Mast cell stabilizers: Sodium cromoglycate, Ketotifen Anti-cholinergics:Ipratropium bromide nasal spray Corticosteroids: Nasal, Oral, Turbinal, Intramuscular Leukotriene receptor antagonists:Montelukast Newer drugs: RhuMAb-25, Altrakincept

  34. Antihistamines & Decongestants AntihistaminesSystemic decongestants • Cetirizine (S)  Phenylephrine • Fexofenadine (S)  Pseudoephedrine • Loratidine (S) Topical decongestants • Levocetrizine (S)  Xylometazoline • Desloratidine (S)  Oxymetazoline • Azelastine (T)  Hypertonic saline

  35. Antihistamines Systemic: Cetirizine: 10 mg OD Fexofenadine: 120 mg OD Loratidine: 10 mg OD Levocetrizine: 5 mg OD Desloratidine: 5 mg OD Topical:Azelastine spray (0.1%): 1-2 puff BD

  36. Nasal Decongestants Systemic decongestants  Phenylephrine  Pseudoephedrine Topical decongestants  Xylometazoline  Oxymetazoline  Saline

  37. Anti-cold preparations PsE = Pseudoephedrine; PhE = Phenylephrine

  38. Topical Decongestants • Oxymetazoline 0.05 %: 2-3 drops BD (NASIVION) • Oxymetazoline 0.025 %: 2 drops BD (NASIVION-P) • Xylometazoline 0.1 %: 3 drops TID (OTRIVIN) • Xylometazoline 0.05 %: 2 drops BD (OTRIVIN-P) • Saline 2 %: 3 drops TID • Saline 0.67 %: 2 drops BD (NASIVION-S)

  39. Systemic Antihistamines

  40. Topical Antihistamine spray

  41. Technique of nasal spray

  42. Nasal Decongestants

  43. Sodium Cromoglycate

  44. Ipratropium nasal spray

  45. Corticosteroids Nasal sprays Injectable  Beclomethasone  Methylprednisolone  Budesonide  Fluticasone Oral  Mometasone  Prednisolone

  46. Corticosteroid nasal spray

  47. Methylprednisolone acetate

  48. Montelukast

  49. Specific Immunotherapy (SIT) Indications: 1. Insufficient response to conventional drugs 2. Side effects from conventional drugs 3. Rejection of conventional drug treatment. 4. Allergy to one or two allergens only Types: Systemic injection, intra-nasal, sublingual

More Related